Form 4 Filing for GeneDx Holdings Corp.

This filing details transactions by Ryan Jason, a director at GeneDx Holdings Corp., on June 18, 2026. Jason acquired 3,576 shares of Class A Common Stock through the exercise of a Restricted Stock Unit (RSU), which vested based on continued service. The RSU, representing a contingent right to one share of Class A Common Stock, was settled for no consideration. Following this transaction, Jason directly holds 15,480 shares of Class A Common Stock. Additionally, the filing notes that 103,284 shares of Class A Common Stock are held indirectly by the Jason Ryan 2024 GRAT, of which Ryan Jason is the trustee and sole annuitant. The entire award of RSUs vests on the earlier of the 2026 annual meeting or the first anniversary of the grant date, subject to continued service.